Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1987 3
1988 1
1989 1
1990 2
1991 2
1992 3
1993 2
1994 1
1996 1
1998 1
2000 1
2001 3
2002 1
2003 3
2004 1
2005 3
2006 7
2007 3
2008 4
2009 3
2010 7
2011 8
2012 2
2013 6
2014 10
2015 6
2016 5
2017 7
2018 6
2019 4
2020 4
2021 6
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Oncolytic virotherapy for the treatment of pediatric brainstem gliomas.
Gállego Pérez-Larraya J, García-Moure M, Alonso MM. Gállego Pérez-Larraya J, et al. Rev Neurol (Paris). 2023 Jun;179(5):475-480. doi: 10.1016/j.neurol.2023.03.016. Epub 2023 Apr 13. Rev Neurol (Paris). 2023. PMID: 37061388 Free article. Review.
Diffuse intrinsic pontine glioma (DIPG) is the most frequent brainstem glioma and the most lethal brain tumor in childhood. Despite transient benefit with radiotherapy, the prognosis of children with this disease remains dismal with severe neurological morbidity and …
Diffuse intrinsic pontine glioma (DIPG) is the most frequent brainstem glioma and the most lethal brain tumor in childhood. De …
Radiotherapy for diffuse brainstem glioma in children and young adults.
Hu X, Fang Y, Hui X, Jv Y, You C. Hu X, et al. Cochrane Database Syst Rev. 2016 Jun 27;2016(6):CD010439. doi: 10.1002/14651858.CD010439.pub2. Cochrane Database Syst Rev. 2016. PMID: 27378212 Free PMC article. Review.
BACKGROUND: Diffuse brainstem glioma is a devastating disease with very poor prognosis. ...We imposed no language restrictions. SELECTION CRITERIA: All randomised controlled trials (RCTs), quasi-randomised trials (QRCTs), or controlled clinical …
BACKGROUND: Diffuse brainstem glioma is a devastating disease with very poor prognosis. ...We imposed no language restrictions …
Diffuse intrinsic pontine gliomas: treatments and controversies.
Bredlau AL, Korones DN. Bredlau AL, et al. Adv Cancer Res. 2014;121:235-259. doi: 10.1016/B978-0-12-800249-0.00006-8. Adv Cancer Res. 2014. PMID: 24889533 Review.
The median survival for children with DIPGs is less than 1 year, in spite of decades of clinical trial development of unique approaches to radiation therapy and chemotherapy. ...
The median survival for children with DIPGs is less than 1 year, in spite of decades of clinical trial development of unique a …
Brainstem gliomas in children and adults.
Laigle-Donadey F, Doz F, Delattre JY. Laigle-Donadey F, et al. Curr Opin Oncol. 2008 Nov;20(6):662-7. doi: 10.1097/CCO.0b013e32831186e0. Curr Opin Oncol. 2008. PMID: 18841048 Review.
However, biopsy remains indicated in many contrast enhancing brainstem masses in adults because of the great variety of differential diagnosis. SUMMARY: Diffuse brainstem glioma is the most common subtype of brainstem tumor and remains a devastating malignancy in ch …
However, biopsy remains indicated in many contrast enhancing brainstem masses in adults because of the great variety of differential diagnos …
Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.
Zhuo Z, Qu L, Zhang P, Duan Y, Cheng D, Xu X, Sun T, Ding J, Xie C, Liu X, Haller S, Barkhof F, Zhang L, Liu Y. Zhuo Z, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4426-4436. doi: 10.1007/s00259-021-05455-4. Epub 2021 Jun 16. Eur J Nucl Med Mol Imaging. 2021. PMID: 34131804
PURPOSE: H3K27M-mutant associated brainstem glioma (BSG) carries a very poor prognosis. We aimed to predict H3K27M mutation status by amide proton transfer-weighted (APTw) imaging and radiomic features. ...H3K27M-mutant prediction using APTw-derived radiomics was co …
PURPOSE: H3K27M-mutant associated brainstem glioma (BSG) carries a very poor prognosis. We aimed to predict H3K27M mutation st …
Advances toward an understanding of brainstem gliomas.
Donaldson SS, Laningham F, Fisher PG. Donaldson SS, et al. J Clin Oncol. 2006 Mar 10;24(8):1266-72. doi: 10.1200/JCO.2005.04.6599. J Clin Oncol. 2006. PMID: 16525181 Review.
The diagnosis of brainstem glioma was long considered a single entity. However, since the advent of magnetic resonance imaging in the late 1980s, neoplasms within this anatomic region are now recognized to include several tumors of varying behavior and natural histo …
The diagnosis of brainstem glioma was long considered a single entity. However, since the advent of magnetic resonance imaging …
Pediatric low grade focal brainstem glioma: outcomes of different treatment strategies and prognostic factors.
Elmaraghi C, Bishr MK, Mousa AG, Ahmed S, Refaat A, Elhemaly A, Ayadi ME, Taha H, Maher E, Elbeltagy M, Zaghloul MS. Elmaraghi C, et al. Future Oncol. 2020 Oct;16(30):2401-2410. doi: 10.2217/fon-2020-0448. Epub 2020 Jul 20. Future Oncol. 2020. PMID: 32687387
Materials & methods: Pediatric FBSG patients diagnosed during 2010-2017 were retrospectively reviewed for clinical and therapeutic data. Results: A total of 71 cases were identified and the median age was 6.4 years. ...Conclusion: Surveillance, radiotherapy and chemoth …
Materials & methods: Pediatric FBSG patients diagnosed during 2010-2017 were retrospectively reviewed for clinical and therapeuti …
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
Monje M, Cooney T, Glod J, Huang J, Peer CJ, Faury D, Baxter P, Kramer K, Lenzen A, Robison NJ, Kilburn L, Vinitsky A, Figg WD, Jabado N, Fouladi M, Fangusaro J, Onar-Thomas A, Dunkel IJ, Warren KE. Monje M, et al. Neuro Oncol. 2023 Dec 8;25(12):2262-2272. doi: 10.1093/neuonc/noad141. Neuro Oncol. 2023. PMID: 37526549 Clinical Trial.
109 results